The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone

Por Slaney, Clare Y., Möller, Andreas, Hertzog, Paul J., Parker, Belinda S.
Publicado em 2013

Clinical application of genetically modified T cells in cancer therapy

Por Kershaw, Michael H, Westwood, Jennifer A, Slaney, Clare Y, Darcy, Phillip K
Publicado no Clin Transl Immunology (2014)

CD73: A potential biomarker for anti-PD-1 therapy

Por Beavis, Paul A, Slaney, Clare Y, Milenkovski, Nicole, Henderson, Melissa A, Loi, Sherene, Stagg, John, Kershaw, Michael H, Darcy, Phillip K
Publicado no Oncoimmunology (2015)

Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene

Por Yong, Carmen S. M., Sharkey, Janelle, Duscio, Belinda, Venville, Ben, Wei, Wei-Zen, Jones, Richard F., Slaney, Clare Y., Mir Arnau, Gisela, Papenfuss, Anthony T., Schröder, Jan, Darcy, Phillip K., Kershaw, Michael H.
Publicado no PLoS One (2015)

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy

Por Beavis, Paul A., Henderson, Melissa A., Giuffrida, Lauren, Mills, Jane K., Sek, Kevin, Cross, Ryan S., Davenport, Alexander J., John, Liza B., Mardiana, Sherly, Slaney, Clare Y., Johnstone, Ricky W., Trapani, Joseph A., Stagg, John, Loi, Sherene, Kats, Lev, Gyorki, David, Kershaw, Michael H., Darcy, Phillip K.
Publicado no J Clin Invest (2017)